Opko Health OPK
NASDAQ OPK
$1.60 -0.06 (-3.61%)
At close: Oct 21, 2026 · 4:00 PM EDT

Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012)

Updated

Opko Health's Preferred Stock Liabilities came in at $24.39 million for Q4 2012, unchanged from $24.39 million a year earlier and unchanged from the prior quarter.

Analysis

Opko Health (OPK) Preferred Stock Liabilities (2011 - 2012) Analysis & Trends

Going back to Q4 2011, Opko Health's Preferred Stock Liabilities data covers 4 quarters.

  • Going back by year, Preferred Stock Liabilities was $24.39 million in FY2011.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn -
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn -
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn -
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Opko Health 1.21 Bn -214.71 Mn 80.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2012 24.39 Mn
Sep 30, 2012 24.39 Mn
Jun 30, 2012 24.39 Mn
Dec 31, 2011 24.39 Mn
API Access

Opko Health Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=OPK&period=max&api_key=YOUR_API_KEY